Nanocrystalline megestrol for nausea caused by chemo
Treatments studied
Part of Cancer clinical trials.
This study tests a new form of megestrol to prevent nausea and vomiting after your first chemotherapy. It is for people who have never had chemo before and are starting a moderately or highly nauseating treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with a solid tumor cancer.
- You have never had chemotherapy (certain treatments like a bladder wash are okay).
- You are about to receive a one-day chemo that is moderately or highly likely to cause nausea.
- Your doctor expects you to live at least 6 more months.
- You are in good general health with adequate blood counts, liver and kidney function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special form of the drug megestrol acetate (Megace) in cancer patients who have lost weight and appetite (cachexia). It aims to see if this medication can help improve weight gain and quality of life.
This trial tests a new form of megestrol acetate to prevent nausea and vomiting caused by chemotherapy in people with advanced stomach cancer who haven't had chemo before. It's for those starting a specific chemo combo that includes a PD-1 inhibitor and CAPOX.
This trial tests a medicine called megestrol acetate to see if it can prevent nausea and vomiting caused by very strong chemotherapy for lung cancer. If you are starting a strong chemo treatment, this study may help you feel better.
This trial tests a newer form of megestrol acetate (a medication that can help with appetite and weight) given alongside standard chemotherapy and radiation for locally advanced cervical cancer that cannot be removed by surgery. The study aims to see if this combination is safe and effective.
This study tests a new form of megestrol (a medicine that can boost appetite and energy) for people with advanced stomach or colorectal cancer who also have fatigue and poor appetite. It is given as a first treatment, meaning you haven't had chemotherapy yet for your advanced cancer.
This trial tests if a new form of megestrol (a medicine that can increase appetite) helps people with advanced lung cancer who are losing weight. It is for patients who have not yet received chemotherapy for their cancer and are at risk of malnutrition.
Hear when a new Malignant Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.